What Zoledronic Acid treats
Zoledronic acid is a bisphosphonate medication used to treat and prevent bone complications in various conditions, including osteoporosis, Paget’s disease of bone, and bone metastases from cancer. It is also used to lower high blood calcium levels (hypercalcemia) caused by malignancy. Zoledronic acid helps to strengthen bones, reduce fracture risk, and slow bone loss by inhibiting bone resorption.
Benefits of Zoledronic Acid
Patients treated with zoledronic acid may experience:
- Increased bone mineral density (BMD)
- Reduced risk of vertebral, hip, and other fractures
- Stabilization of bone lesions in cancer
- Correction of high blood calcium levels
- Convenient once-yearly dosing for osteoporosis management
Its long-acting effect and IV delivery make it a reliable option for patients who require strong and sustained bone protection.
Possible Side Effects of Zoledronic Acid
Common side effects may include:
- Flu-like symptoms (fever, chills, muscle aches) shortly after infusion
- Headache
- Fatigue
- Nausea
Less common but serious risks include:
- Kidney dysfunction (renal monitoring is required)
- Low blood calcium (hypocalcemia)
- Osteonecrosis of the jaw (more common in cancer patients)
- Atypical femur fractures with long-term use
Pre-infusion bloodwork and post-treatment monitoring help ensure safety.
How infusion works at Prime
Zoledronic Acid is administered at our infusion centers across New York and Atlanta. Our dedicated care team coordinates every step of your treatment with your prescribing physician.
Getting started
Patients: if you have a referral for Zoledronic Acid, send us an inquiry using the form below and our care team will take it from there. Physicians: referring a patient to Prime Infusions is simple — just complete and fax or email the referral form above.
Ready to start?
For a medical emergency, call 911.
Our Infusion Centers
FAQ
Frequently asked questions
How Does Zoledronic Acid Work?
Zoledronic acid works by inhibiting osteoclasts—cells that break down bone tissue. In many diseases, overactive osteoclasts lead to excessive bone loss and structural weakness. By reducing osteoclast activity, zoledronic acid helps maintain or improve bone density and reduces the risk of fractures and skeletal-related events (SREs). It is administered as a once-yearly intravenous infusion for osteoporosis, or at more frequent intervals for oncology indications.
Who is Zoledronic Acid For?
Zoledronic acid is indicated for:
- Postmenopausal women and men with osteoporosis
- Individuals with a history of osteoporotic fractures
- Patients with Paget’s disease of bone
- Cancer patients with bone metastases or multiple myeloma
- Patients with hypercalcemia of malignancy
It is often used when oral bisphosphonates are not effective or tolerated, or when rapid treatment is needed.